Cross-neutralization of SARS-CoV-2 BA.3.2.2 lineage by JN.1 mRNA vaccine-induced immunity. Miyakawa K, Sano K, Seki Y, Sato R, et al. Int J Infect Dis 2026 Jul 4:108954. doi: 10.1016/j.ijid.2026.108954.

Read + Share

Amedeo Smart

Independent Medical Education

Miyakawa K, Sano K, Seki Y, Sato R, et al. Cross-neutralization of SARS-CoV-2 BA.3.2.2 lineage by JN.1 mRNA vaccine-induced immunity. Int J Infect Dis 2026 Jul 4:108954. doi: 10.1016/j.ijid.2026.108954.
PMID: 42401363